Cerence Inc. (CRNC) PT Lowered to $78 at Needham & Company

Needham & Company analyst Rajvindra Gill lowered the price target on Cerence Inc. (NASDAQ: CRNC) to $78.00 (from $165.00) while maintaining a Buy rating following the miss and lower guidance.

The firm is maintaining the Buy citing:

1) 2nd highest bookings qrt;

2) Connected revenue will still grow in FY23;

3) P/E multiple contacted 32%.

You May Also Be Interested In

• Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
• Wedbush Downgrades Tscan Therapeutics Inc (TCRX) to Neutral
• Comstock Resources (CRK) PT Raised to $17 at BMO Capital